Breaking News Instant updates and real-time market news.

MTA

Metalla Royalty & Streaming

$5.16 /

-0.03 (-0.58%)

, AG

First Majestic

$9.49 /

-0.13 (-1.35%)

07:18
11/28/22
11/28
07:18
11/28/22
07:18

Metalla to acquire royalty portfolio from First Majestic for $20M

Metalla Royalty & Streaming (MTA) announces that on November 26, 2022 it signed a royalty purchase agreement with First Majestic Silver (AG), pursuant to which Metalla will acquire eight royalties for $20M of common shares of Metalla. First Majestic holds and will originate a portfolio of royalties in Mexico. Transaction Highlights: The addition of the producing La Encantada gold royalty will provide immediate cash flow to Metalla; The portfolio adds four near term silver development royalties, most of which are fully permitted, have existing infrastructure and mine development; The combined land package covers more than 175,000 hectares across some of the most prolific silver camps in Mexico; The addition of eight royalties from First Majestic will expand Metalla's portfolio to 79 royalties and streams; Counterparties include First Majestic, Sierra Madre Gold and Silver, GR Silver Mining and Silver Dollar Resources ; The royalty portfolio is predominantly silver and will add approximately 1.7Moz of attributable silver in the measured and indicated categories, and 5.2Moz of attributable silver in the inferred category to Metalla9. Brett Heath, President, and CEO of Metalla, commented, "This transaction marks another important milestone in our continued growth at Metalla. It provides shareholders with eight new royalties that have a significant amount of exposure and leverage to silver. It adds immediate cash flow from one producing royalty, bolsters our near-term development pipeline with four development royalties, and three advanced exploration royalties. It also adds a significant amount of exploration upside with over 175,000 hectares of royalty coverage across the most prolific silver trends in Mexico." The aggregate consideration payable by Metalla for the purchase of the royalties will be satisfied by Metalla issuing $20 million of common shares based on the 25-day volume-weighted average price of shares traded on the NYSE American prior to this announcement at a price of US$4.7984 to be issued upon closing. The Transaction is subject to customary closing conditions and exchange approvals and is expected to close in Q1 2023.

MTA

Metalla Royalty & Streaming

$5.16 /

-0.03 (-0.58%)

AG

First Majestic

$9.49 /

-0.13 (-1.35%)

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Biogen says BIIB080 'substantially reduced' tau protein level in early-stage AD » 08:54
03/29/23
03/29
08:54
03/29/23
08:54
BIIB

Biogen

$270.29 /

+0.66 (+0.24%)

Biogen reported Phase 1b…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$270.29 /

+0.66 (+0.24%)

BIIB Biogen
$270.29 /

+0.66 (+0.24%)

03/21/23 BofA
FDA briefing docs suggest FDA in favor of Biogen's tofersen, says BofA
03/17/23 Stifel
Stifel trims Biogen target, but has more confidence lecanemab 'best-in-class'
03/13/23 RBC Capital
Biogen price target raised to $350 from $335 at RBC Capital
03/09/23 BofA
No ad com suggests positive potential outcome for Sage's zura, says BofA
BIIB Biogen
$270.29 /

+0.66 (+0.24%)

BIIB Biogen
$270.29 /

+0.66 (+0.24%)

BIIB Biogen
$270.29 /

+0.66 (+0.24%)

BIIB Biogen
$270.29 /

+0.66 (+0.24%)

Initiation
Baxter initiated with a Neutral at UBS » 08:53
03/29/23
03/29
08:53
03/29/23
08:53
BAX

Baxter

$39.86 /

-0.215 (-0.54%)

UBS analyst Danielle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAX Baxter
$39.86 /

-0.215 (-0.54%)

BAX Baxter
$39.86 /

-0.215 (-0.54%)

03/28/23 UBS
Baxter initiated with a Neutral at UBS
02/13/23 Barclays
Baxter price target lowered to $54 from $63 at Barclays
02/10/23 Cowen
Baxter price target lowered to $45 from $70 at Cowen
02/06/23 KeyBanc
Baxter price target lowered to $60 from $73 at KeyBanc
BAX Baxter
$39.86 /

-0.215 (-0.54%)

BAX Baxter
$39.86 /

-0.215 (-0.54%)

BAX Baxter
$39.86 /

-0.215 (-0.54%)

BAX Baxter
$39.86 /

-0.215 (-0.54%)

Initiation
Johnson & Johnson assumed with a Neutral at UBS » 08:51
03/29/23
03/29
08:51
03/29/23
08:51
JNJ

Johnson & Johnson

$151.81 /

-1.45 (-0.95%)

UBS assumed coverage of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$151.81 /

-1.45 (-0.95%)

JNJ Johnson & Johnson
$151.81 /

-1.45 (-0.95%)

03/28/23 UBS
Johnson & Johnson initiated with a Neutral at UBS
03/13/23 Stifel
Arcellx initiated with a Buy at Stifel
03/01/23 Guggenheim
Johnson & Johnson initiated with a Neutral, $161 price target at Guggenheim
02/28/23 Guggenheim
Johnson & Johnson initiated with a Neutral at Guggenheim
JNJ Johnson & Johnson
$151.81 /

-1.45 (-0.95%)

JNJ Johnson & Johnson
$151.81 /

-1.45 (-0.95%)

JNJ Johnson & Johnson
$151.81 /

-1.45 (-0.95%)

JNJ Johnson & Johnson
$151.81 /

-1.45 (-0.95%)

Hot Stocks
United Health Products reports anomalies from lab testing of HemoStyp samples » 08:50
03/29/23
03/29
08:50
03/29/23
08:50
UEEC

United Health Products

/

+

United Health Products…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UEEC United Health Products
/

+

Initiation
Abbott assumed with a Buy at UBS » 08:49
03/29/23
03/29
08:49
03/29/23
08:49
ABT

Abbott

$97.10 /

-1.345 (-1.37%)

UBS analyst Danielle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABT Abbott
$97.10 /

-1.345 (-1.37%)

ABT Abbott
$97.10 /

-1.345 (-1.37%)

03/28/23 UBS
Abbott initiated with a Buy at UBS
03/08/23 Jefferies
DexCom pullback on Abbott news a buying opportunity, says Jefferies
03/08/23 Wells Fargo
Wells downgrades Edwards Lifesciences with Medtronic gaining share
03/07/23 BofA
BofA says buy DexCom on weakness after Abbott's Libre gets pump integration
ABT Abbott
$97.10 /

-1.345 (-1.37%)

ABT Abbott
$97.10 /

-1.345 (-1.37%)

ABT Abbott
$97.10 /

-1.345 (-1.37%)

ABT Abbott
$97.10 /

-1.345 (-1.37%)

Hot Stocks
Ionis Pharmaceuticals' IONIS-MAPTRx shows tau reduction efficacy in Alzheimer's » 08:49
03/29/23
03/29
08:49
03/29/23
08:49
IONS

Ionis Pharmaceuticals

$34.30 /

+0.575 (+1.71%)

, BIIB

Biogen

$270.29 /

+0.66 (+0.24%)

Ionis Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IONS Ionis Pharmaceuticals
$34.30 /

+0.575 (+1.71%)

BIIB Biogen
$270.29 /

+0.66 (+0.24%)

IONS Ionis Pharmaceuticals
$34.30 /

+0.575 (+1.71%)

03/21/23 Bernstein
Ionis Pharmaceuticals initiated with an Underperform at Bernstein
02/23/23 SVB Securities
Ionis Pharmaceuticals price target lowered to $27 from $34 at SVB Securities
02/23/23 Barclays
Ionis Pharmaceuticals price target lowered to $40 from $44 at Barclays
01/19/23 Piper Sandler
Ionis Pharmaceuticals price target raised to $62 from $60 at Piper Sandler
BIIB Biogen
$270.29 /

+0.66 (+0.24%)

03/21/23 BofA
FDA briefing docs suggest FDA in favor of Biogen's tofersen, says BofA
03/17/23 Stifel
Stifel trims Biogen target, but has more confidence lecanemab 'best-in-class'
03/13/23 RBC Capital
Biogen price target raised to $350 from $335 at RBC Capital
03/09/23 BofA
No ad com suggests positive potential outcome for Sage's zura, says BofA
IONS Ionis Pharmaceuticals
$34.30 /

+0.575 (+1.71%)

BIIB Biogen
$270.29 /

+0.66 (+0.24%)

BIIB Biogen
$270.29 /

+0.66 (+0.24%)

IONS Ionis Pharmaceuticals
$34.30 /

+0.575 (+1.71%)

BIIB Biogen
$270.29 /

+0.66 (+0.24%)

BIIB Biogen
$270.29 /

+0.66 (+0.24%)

Recommendations
VF Corp. price target lowered to $24 from $28 at UBS » 08:48
03/29/23
03/29
08:48
03/29/23
08:48
VFC

VF Corp.

$21.21 /

+0.375 (+1.80%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VFC VF Corp.
$21.21 /

+0.375 (+1.80%)

VFC VF Corp.
$21.21 /

+0.375 (+1.80%)

03/20/23 Williams Trading
VF Corp. double upgraded to Buy at Williams Trading after management meetings
03/20/23 Baird
VF Corp. price target lowered to $24 from $30 at Baird
03/20/23 Williams Trading
VF Corp. upgraded to Buy from Sell at Williams Trading
02/10/23 Stifel
VF Corp. upgraded to Buy from Hold at Stifel
VFC VF Corp.
$21.21 /

+0.375 (+1.80%)

VFC VF Corp.
$21.21 /

+0.375 (+1.80%)

VFC VF Corp.
$21.21 /

+0.375 (+1.80%)

Hot Stocks
Conduent implements child support payment processing system in New Hampshire » 08:48
03/29/23
03/29
08:48
03/29/23
08:48
CNDT

Conduent

$3.15 /

-0.02 (-0.63%)

Conduent announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNDT Conduent
$3.15 /

-0.02 (-0.63%)

CNDT Conduent
$3.15 /

-0.02 (-0.63%)

05/31/22 Gordon Haskett
Conduent 'overdue to be sold,' says Gordon Haskett
CNDT Conduent
$3.15 /

-0.02 (-0.63%)

Recommendations
Under Armour price target lowered to $15 from $16 at UBS » 08:48
03/29/23
03/29
08:48
03/29/23
08:48
UAA

Under Armour

/

+

, UA

Under Armour

$8.04 /

+0.03 (+0.37%)

UBS lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UAA Under Armour
/

+

UA Under Armour
$8.04 /

+0.03 (+0.37%)

UAA Under Armour
/

+

03/21/23 Evercore ISI
Foot Locker upgraded to Outperform from In Line at Evercore ISI
03/16/23 Williams Trading
Under Armour upgraded to Buy from Hold at Williams Trading
03/16/23 Redburn
Under Armour initiated with a Buy at Redburn
03/13/23 JPMorgan
Under Armour downgraded to Neutral from Overweight at JPMorgan
UA Under Armour
$8.04 /

+0.03 (+0.37%)

03/21/23 Evercore ISI
Foot Locker upgraded to Outperform from In Line at Evercore ISI
03/16/23 Williams Trading
Under Armour upgraded to Buy from Hold at Williams Trading
03/16/23 Redburn
Under Armour initiated with a Buy at Redburn
03/13/23 JPMorgan
Under Armour downgraded to Neutral from Overweight at JPMorgan
UAA Under Armour
/

+

UA Under Armour
$8.04 /

+0.03 (+0.37%)

UAA Under Armour
/

+

UA Under Armour
$8.04 /

+0.03 (+0.37%)

UAA Under Armour
/

+

Initiation
Intuitive Surgical assumed with a Neutral at UBS » 08:48
03/29/23
03/29
08:48
03/29/23
08:48
ISRG

Intuitive Surgical

$249.55 /

-2.74 (-1.09%)

UBS analyst Danielle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ISRG Intuitive Surgical
$249.55 /

-2.74 (-1.09%)

ISRG Intuitive Surgical
$249.55 /

-2.74 (-1.09%)

03/28/23 UBS
Intuitive Surgical initiated with a Neutral at UBS
03/24/23 Evercore ISI
Evercore says Intuitive Surgical outperformance tied to new system speculation
03/23/23 William Blair
William Blair starts Intuitive Surgical at Outperform on favorable risk/reward
03/23/23 William Blair
Intuitive Surgical initiated with an Outperform at William Blair
ISRG Intuitive Surgical
$249.55 /

-2.74 (-1.09%)

ISRG Intuitive Surgical
$249.55 /

-2.74 (-1.09%)

ISRG Intuitive Surgical
$249.55 /

-2.74 (-1.09%)

Recommendations
Tapestry price target lowered to $42 from $44 at UBS » 08:48
03/29/23
03/29
08:48
03/29/23
08:48
TPR

Tapestry

$41.73 /

+0.99 (+2.43%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPR Tapestry
$41.73 /

+0.99 (+2.43%)

TPR Tapestry
$41.73 /

+0.99 (+2.43%)

02/10/23 Morgan Stanley
Tapestry assumed with an Equal Weight at Morgan Stanley
02/10/23 Baird
Tapestry price target raised to $52 from $45 at Baird
01/23/23 Barclays
Capri Holdings price target raised to $72 from $56 at Barclays
01/23/23 Barclays
Tapestry downgraded to Equal Weight from Overweight at Barclays
TPR Tapestry
$41.73 /

+0.99 (+2.43%)

TPR Tapestry
$41.73 /

+0.99 (+2.43%)

TPR Tapestry
$41.73 /

+0.99 (+2.43%)

TPR Tapestry
$41.73 /

+0.99 (+2.43%)

Recommendations
Skechers price target lowered to $60 from $69 at UBS » 08:47
03/29/23
03/29
08:47
03/29/23
08:47
SKX

Skechers

$45.78 /

+1.155 (+2.59%)

UBS lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SKX Skechers
$45.78 /

+1.155 (+2.59%)

SKX Skechers
$45.78 /

+1.155 (+2.59%)

02/03/23 UBS
Skechers price target raised to $69 from $63 at UBS
02/03/23 Cowen
Skechers price target lowered to $62 from $65 at Cowen
01/23/23 Cowen
Skechers upgraded to Outperform at Cowen on momentum and margin recovery
01/23/23 Deutsche Bank
Skechers price target raised to $54 from $43 at Deutsche Bank
SKX Skechers
$45.78 /

+1.155 (+2.59%)

SKX Skechers
$45.78 /

+1.155 (+2.59%)

SKX Skechers
$45.78 /

+1.155 (+2.59%)

Recommendations
Ralph Lauren price target lowered to $154 from $157 at UBS » 08:47
03/29/23
03/29
08:47
03/29/23
08:47
RL

Ralph Lauren

$115.54 /

+2.77 (+2.46%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RL Ralph Lauren
$115.54 /

+2.77 (+2.46%)

RL Ralph Lauren
$115.54 /

+2.77 (+2.46%)

02/13/23 BofA
Ralph Lauren upgraded to Buy from Neutral at BofA
02/10/23 Deutsche Bank
Ralph Lauren price target raised to $119 from $114 at Deutsche Bank
02/10/23 Cowen
Ralph Lauren price target raised to $151 from $148 at Cowen
02/10/23 Credit Suisse
Ralph Lauren price target raised to $135 from $115 at Credit Suisse
RL Ralph Lauren
$115.54 /

+2.77 (+2.46%)

RL Ralph Lauren
$115.54 /

+2.77 (+2.46%)

RL Ralph Lauren
$115.54 /

+2.77 (+2.46%)

Recommendations
Children's Place price target lowered to $40 from $45 at UBS » 08:47
03/29/23
03/29
08:47
03/29/23
08:47
PLCE

Children's Place

$38.28 /

+0.25 (+0.66%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLCE Children's Place
$38.28 /

+0.25 (+0.66%)

PLCE Children's Place
$38.28 /

+0.25 (+0.66%)

02/07/23 Telsey Advisory
Children's Place downgraded to Market Perform from Outperform at Telsey
11/18/22 UBS
Children's Place price target lowered to $41 from $43 at UBS
08/18/22 B. Riley
Children's Place price target lowered to $64 from $69 at B. Riley
08/16/22 B. Riley
Children's Place price target lowered to $69 from $84 at B. Riley
PLCE Children's Place
$38.28 /

+0.25 (+0.66%)

PLCE Children's Place
$38.28 /

+0.25 (+0.66%)

Initiation
Medtronic assumed with a Sell at UBS » 08:47
03/29/23
03/29
08:47
03/29/23
08:47
MDT

Medtronic

/

+

UBS assumed coverage of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDT Medtronic
/

+

MDT Medtronic
/

+

03/28/23 UBS
Medtronic assumed at Sell from Buy at UBS
03/28/23 UBS
Medtronic downgraded to Sell from Buy at UBS
03/08/23 Wells Fargo
Wells downgrades Edwards Lifesciences with Medtronic gaining share
02/22/23 Deutsche Bank
Medtronic price target raised to $87 from $80 at Deutsche Bank
MDT Medtronic
/

+

MDT Medtronic
/

+

MDT Medtronic
/

+

MDT Medtronic
/

+

Recommendations
Kontoor Brands price target lowered to $65 from $66 at UBS » 08:47
03/29/23
03/29
08:47
03/29/23
08:47
KTB

Kontoor Brands

$47.88 /

+0.7 (+1.48%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTB Kontoor Brands
$47.88 /

+0.7 (+1.48%)

KTB Kontoor Brands
$47.88 /

+0.7 (+1.48%)

03/08/23 UBS
Kontoor Brands price target raised to $66 from $54 at UBS
03/07/23 Barclays
Kontoor Brands price target raised to $51 from $37 at Barclays
03/01/23 Wells Fargo
Kontoor Brands price target raised to $59 from $48 at Wells Fargo
02/28/23 Stifel
Kontoor Brands upgraded to Buy at Stifel amid brand momentum, share gains
KTB Kontoor Brands
$47.88 /

+0.7 (+1.48%)

KTB Kontoor Brands
$47.88 /

+0.7 (+1.48%)

Recommendations
nCino price target lowered to $33 from $35 at Needham » 08:46
03/29/23
03/29
08:46
03/29/23
08:46
NCNO

nCino

$22.35 /

-0.01 (-0.04%)

Needham analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NCNO nCino
$22.35 /

-0.01 (-0.04%)

NCNO nCino
$22.35 /

-0.01 (-0.04%)

07:46 Today Truist
nCino price target lowered to $40 from $45 at Truist
07:30 Today BofA
nCino price target lowered to $30 from $32 at BofA
05:29 Today Barclays
nCino price target lowered to $26 from $35 at Barclays
03/24/23 Morgan Stanley
nCino price target lowered to $27 from $35 at Morgan Stanley
NCNO nCino
$22.35 /

-0.01 (-0.04%)

NCNO nCino
$22.35 /

-0.01 (-0.04%)

NCNO nCino
$22.35 /

-0.01 (-0.04%)

Recommendations
Kohl's price target lowered to $16 from $18 at UBS » 08:46
03/29/23
03/29
08:46
03/29/23
08:46
KSS

Kohl's

$21.77 /

+0.09 (+0.42%)

UBS lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KSS Kohl's
$21.77 /

+0.09 (+0.42%)

KSS Kohl's
$21.77 /

+0.09 (+0.42%)

03/02/23 Deutsche Bank
Kohl's price target lowered to $31 from $34 at Deutsche Bank
03/02/23 Citi
Kohl's price target lowered to $26 from $29 at Citi
03/02/23 Morgan Stanley
Kohl's assumed with an Underweight at Morgan Stanley
03/01/23 Credit Suisse
Credit Suisse lowers Kohl's price target to $27 following quarterly results
KSS Kohl's
$21.77 /

+0.09 (+0.42%)

KSS Kohl's
$21.77 /

+0.09 (+0.42%)

KSS Kohl's
$21.77 /

+0.09 (+0.42%)

KSS Kohl's
$21.77 /

+0.09 (+0.42%)

Earnings
Cintas reports Q3 EPS $3.14, consensus $3.04 » 08:46
03/29/23
03/29
08:46
03/29/23
08:46
CTAS

Cintas

$443.89 /

+3.48 (+0.79%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTAS Cintas
$443.89 /

+3.48 (+0.79%)

CTAS Cintas
$443.89 /

+3.48 (+0.79%)

12/22/22 Wells Fargo
Cintas price target raised to $450 from $393 at Wells Fargo
12/22/22 Deutsche Bank
Cintas price target raised to $507 from $490 at Deutsche Bank
12/22/22 Baird
Cintas price target raised to $500 from $475 at Baird
12/22/22 Morgan Stanley
Cintas price target raised to $401 from $373 at Morgan Stanley
CTAS Cintas
$443.89 /

+3.48 (+0.79%)

CTAS Cintas
$443.89 /

+3.48 (+0.79%)

Recommendations
Hanesbrands price target lowered to $5 from $7 at UBS » 08:46
03/29/23
03/29
08:46
03/29/23
08:46
HBI

Hanesbrands

$5.11 /

+0.1 (+2.00%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HBI Hanesbrands
$5.11 /

+0.1 (+2.00%)

HBI Hanesbrands
$5.11 /

+0.1 (+2.00%)

02/03/23 Citi
Hanesbrands price target lowered to $7 from $8 at Citi
01/13/23 Barclays
Hanesbrands price target raised to $8 from $7 at Barclays
11/09/22 Credit Suisse
Hanesbrands downgraded to Neutral from Outperform at Credit Suisse
11/06/22 Citi
Hanesbrands price target lowered to $7 from $11 at Citi
HBI Hanesbrands
$5.11 /

+0.1 (+2.00%)

HBI Hanesbrands
$5.11 /

+0.1 (+2.00%)

HBI Hanesbrands
$5.11 /

+0.1 (+2.00%)

Recommendations
Canada Goose price target lowered to $20 from $23 at UBS » 08:46
03/29/23
03/29
08:46
03/29/23
08:46
GOOS

Canada Goose

$18.02 /

-0.005 (-0.03%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOS Canada Goose
$18.02 /

-0.005 (-0.03%)

GOOS Canada Goose
$18.02 /

-0.005 (-0.03%)

02/17/23 Evercore ISI
Canada Goose downgraded to In Line from Outperform at Evercore ISI
02/08/23 Credit Suisse
Canada Goose price target raised to C$36 from C$30 at Credit Suisse
02/06/23 Barclays
Canada Goose price target raised to $21 from $20 at Barclays
02/03/23 Cowen
Canada Goose price target lowered to $22 from $26 at Cowen
GOOS Canada Goose
$18.02 /

-0.005 (-0.03%)

GOOS Canada Goose
$18.02 /

-0.005 (-0.03%)

GOOS Canada Goose
$18.02 /

-0.005 (-0.03%)

Recommendations
Designer Brands price target lowered to $10 from $11 at UBS » 08:45
03/29/23
03/29
08:45
03/29/23
08:45
DBI

Designer Brands

$8.74 /

+0.085 (+0.98%)

UBS lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DBI Designer Brands
$8.74 /

+0.085 (+0.98%)

DBI Designer Brands
$8.74 /

+0.085 (+0.98%)

12/02/22 Deutsche Bank
Designer Brands price target lowered to $16 from $20 at Deutsche Bank
09/01/22 Deutsche Bank
Designer Brands price target raised to $20 from $19 at Deutsche Bank
07/15/22 UBS
Designer Brands price target lowered to $14 from $17 at UBS
06/03/22 Deutsche Bank
Designer Brands price target raised to $22 from $20 at Deutsche Bank
DBI Designer Brands
$8.74 /

+0.085 (+0.98%)

DBI Designer Brands
$8.74 /

+0.085 (+0.98%)

Initiation
Edwards Lifesciences initiated with a Neutral at UBS » 08:45
03/29/23
03/29
08:45
03/29/23
08:45
EW

Edwards Lifesciences

/

+

UBS analyst Danielle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EW Edwards Lifesciences
/

+

EW Edwards Lifesciences
/

+

03/28/23 UBS
Edwards Lifesciences initiated with a Neutral at UBS
03/08/23 Wells Fargo
Wells downgrades Edwards Lifesciences with Medtronic gaining share
03/08/23 Wells Fargo
Edwards Lifesciences downgraded to Equal Weight from Overweight at Wells Fargo
02/06/23 Raymond James
Edwards Lifesciences downgraded to Market Perform from Outperform at Raymond James
EW Edwards Lifesciences
/

+

EW Edwards Lifesciences
/

+

EW Edwards Lifesciences
/

+

Recommendations
Carter's price target lowered to $65 from $74 at UBS » 08:45
03/29/23
03/29
08:45
03/29/23
08:45
CRI

Carter's

$70.68 /

+1.085 (+1.56%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRI Carter's
$70.68 /

+1.085 (+1.56%)

01/26/23 Wedbush
Wedbush downgrades Carter's to Neutral as post-COVID 'baby boom" fizzles out
01/26/23 Wedbush
Carter's downgraded to Neutral from Outperform at Wedbush
08/01/22 B. Riley
Carter's price target lowered to $99 from $114 at B. Riley
08/01/22 UBS
Carter's price target raised to $86 from $72 at UBS
CRI Carter's
$70.68 /

+1.085 (+1.56%)

CRI Carter's
$70.68 /

+1.085 (+1.56%)

Recommendations
Capri Holdings price target lowered to $59 from $68 at UBS » 08:45
03/29/23
03/29
08:45
03/29/23
08:45
CPRI

Capri Holdings

/

+

UBS lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
/

+

CPRI Capri Holdings
/

+

02/13/23 Cowen
Capri Holdings downgraded to Market Perform from Outperform at Cowen
02/09/23 BMO Capital
Capri Holdings price target lowered to $70 from $74 at BMO Capital
02/09/23 Morgan Stanley
Capri Holdings assumed with an Overweight at Morgan Stanley
02/09/23 UBS
Capri Holdings price target lowered to $68 from $75 at UBS
CPRI Capri Holdings
/

+

CPRI Capri Holdings
/

+

CPRI Capri Holdings
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.